Duchenne Muscular Dystrophy Treatment in Turkey
About Duchenne Muscular Dystrophy
Key Highlights
-
Targets the root genetic cause of DMD, not just symptoms.Offers personalized treatment plans based on the patient's specific genetic mutation.Includes innovative therapies like exon-skipping to promote dystrophin production.Aims to slow disease progression and preserve muscle strength and function.Managed by a specialized multidisciplinary team for comprehensive care.Represents the forefront of precision medicine for neuromuscular disorders./ul
Who is this surgery for?
- Confirmed diagnosis of Duchenne Muscular Dystrophy via genetic testing and clinical evaluation.
- Identification of a specific mutation in the DMD gene that is amenable to targeted therapies like exon-skipping.
- Early intervention, often in childhood, to maximize potential therapeutic benefits.
- As part of a comprehensive management plan including physical therapy and cardiac/respiratory care.
- For patients and families seeking the latest precision medicine options beyond standard supportive care.
How to prepare
- Comprehensive genetic counseling for the patient and family to understand the diagnosis, inheritance, and treatment options.
- Full genetic sequencing and analysis to pinpoint the exact DMD gene mutation.
- Baseline physical assessments including muscle strength, pulmonary function, and cardiac evaluations.
- Multidisciplinary team consultation to develop an integrated care plan.
- Discussion of potential benefits, limitations, and long-term commitment required for genetic therapies.
- Ensuring the patient is medically stable to begin treatment, managing any concurrent health issues.
Risks & possible complications
- Potential side effects specific to the genetic agent used (e.g., injection site reactions, kidney toxicity with some exon-skipping drugs).
- Risk of immune reactions to the viral vectors used in some gene transfer therapies.
- Uncertain long-term efficacy and unknown very long-term safety profile of novel genetic medicines.
- High financial cost and potential challenges with insurance coverage.
- Emotional and psychological impact on the patient and family due to the progressive nature of DMD, even with treatment.
- Not all mutations are currently treatable with available genetic therapies.
Recovery & hospital stay
- Genetic medicine for DMD is typically a chronic, ongoing treatment, not a one-time procedure with a traditional 'recovery' period.
- Regular monitoring is essential, including periodic physical exams, muscle function tests, and safety labs.
- Continued commitment to standard of care is crucial: rigorous physical therapy, respiratory support, and cardiac management.
- Families should maintain a log of any new symptoms or side effects to report to the care team.
- Outpatient follow-up appointments are scheduled frequently (e.g., every 3-6 months initially) to assess progress and adjust the care plan.
- Psychological support and connection with patient advocacy groups are highly recommended for ongoing coping.
-
Typical hospital stay:
Typically outpatient / 0 days (for infusions or evaluations, may require day-care)
-
Expected recovery time:
Ongoing chronic treatment; initial adaptation period of 2-4 weeks post-treatment initiation
Frequently Asked Questions
If you are considering duchenne muscular dystrophy in Turkey, these questions and answers can help you make a confident, informed decision.
Top-rated hospitals in Turkey with genetic medicine departments and experienced surgeons are ideal for this procedure. Use MediFyr to compare facilities, reviews, and doctor profiles before you decide.
Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform duchenne muscular dystrophy. MediFyr helps you compare genetic medicines and book consultations online.
The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.
Procedure cost in other countries
Here is an overview of how the estimated cost, hospital stay, and recovery time for duchenne muscular dystrophy compare across other countries where we have data.
| Country | Estimated cost range | Typical stay | Recovery time | View details |
|---|---|---|---|---|
| India | USD 5,438 – USD 27,192 | Typically outpatient / 0 days (for infusions or evaluations, may require day-care) | ~ Ongoing chronic treatment; initial adaptation period of 2-4 weeks post-treatment initiation | Know More |
| Turkey | USD 40,263 – USD 201,313 | Typically outpatient / 0 days (for infusions or evaluations, may require day-care) | ~ Ongoing chronic treatment; initial adaptation period of 2-4 weeks post-treatment initiation | Know More |
As a 72-year-old retired botanist with...
As a 72-year-old retired botanist with unexplained neurological decline, I was misdiagnosed for years until Dr. Grace Swarna Priya identified my rare ATXN2 gene mutation. Her personalized management plan at MIOT Hospital has slowed my progression remarkably, I can now enjoy gardening again with adapted tools.